Open AccessS105: IN VIVO PDX CRISPR/CAS9 SCREENS REVEAL MUTUAL THERAPEUTIC TARGETS TO OVERCOME HETEROGENEOUS ACQUIRED CHEMO‐RESISTANCE
Author(s) -
Wirth A.K.,
Wange L.,
Vosberg S.,
Jayavelu A. K.,
Enard W,
Herold T,
Jeremias I
Publication year - 2022
Publication title -
hemasphere
Language(s) - Uncategorized
Resource type - Journals
SCImago Journal Rank - 0.677
H-Index - 11
ISSN - 2572-9241
DOI - 10.1097/01.hs9.0000843316.54415.69
Subject(s) - crispr , in vivo , biology , transcriptome , cancer research , minimal residual disease , computational biology , bioinformatics , gene , leukemia , genetics , gene expression